Corient Private Wealth
MDLN

Corient Private Wealth’s Medline Inc MDLN Stock Holding History

Corient Private Wealth’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Buy
27,097
+14,365
+113% +$634K ﹤0.01% 1568
2025
Q4 		$535K Buy
+12,732
New +$538K ﹤0.01% 2264

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Corient Private Wealth's MDLN Position: Q1 2026 in Review

Corient Private Wealth increased its Medline Inc (MDLN) stake by 113% in Q1 2026, buying an estimated $634K and bringing the position to 27,097 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Corient Private Wealth first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Corient Private Wealth held 27,097 shares of Medline Inc worth $1.17M as of Q1 2026.
  • Corient Private Wealth bought 14,365 Medline Inc shares in Q1 2026, an estimated $634K.
  • Medline Inc made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1568 holding.
  • Corient Private Wealth first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.